Search results
We think Prothena Corporation plc's (NASDAQ:PRTA) CEO May Struggle To See Much Of A Pay Rise This...
Simply Wall St. via Yahoo Finance· 4 days agoThis is something shareholders will keep in mind as they cast their votes on company resolutions...
Celebrity News | Entertainment News | TMZ.com
TMZ· 2 days agoArticles - July, 2018 Will Smith -- Good Genes or Good Docs? NBA Owner's Daughter Says Becky Hammon Will Change NBA Forever Sexy Canadian Stars ... Eh? MLB's Christian Yelich Buys $5.6 mil Malibu Beach Pad,
How Editas 'dragged' Linda Burkly over as CSO after 37 years at Biogen
FierceBiotech· 2 days agoAfter...me from Biogen,” Burkly said in an interview on the sidelines of the American Society of ...
Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 days agoErik Holmlin -- Chief Executive Officer Thank you, David, and good afternoon, everyone. We...
Q1 2024 Editas Medicine Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoNow I will turn the call over to our CEO, Gilmore O’Neill. Gilmore O’Neill Thanks, Christy, and good morning, everyone. Thank you for joining us today.
Impossible Foods CEO on the importance of first impressions
Food Dive via Yahoo Finance· 5 days agoImpossible says that it makes the ingredient by using a yeast genetically engineered with the gene...
Q1 2024 Viatris Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoWe have an incredibly talented team. And we have clear plans to deliver on our key R&D objectives to support Viatris' overall growth. Now I will turn the call over to Doretta to work through ...
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Motley Fool via Yahoo Finance· 2 days agoHe's obviously not alone in the accolades for Accolade. Wood sees this as a good entry point as...
Q1 2024 Bio Rad Laboratories Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days agoDuring Q1, we also released a new Multiplex Mutation Detection Assay, providing a comprehensive status readout of mutations in ESR-1, which is a key gene in breast cancer.
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Target Price at $15.40
ETF DAILY NEWS· 1 day agoTenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) has been given a consensus rating of “Buy” by the seven analysts that are covering the stock, Marketbeat.com reports. Canaccord Genuity ...